^
    11ms
    First report of furmonertinib as a first-line treatment in advanced lung adenocarcinoma patients harboring EGFR exon 20 insertion mutations after the kinase domain αC-helix: Two case reports and a literature review. (PubMed, Medicine (Baltimore))
    The present study indicates that furmonertinib may be a first-line treatment option for patients with non-small cell lung cancer harboring EGFR ex20ins mutation.
    Review • Journal • EGFR exon 20 • Metastases
    |
    EGFR (Epidermal growth factor receptor)
    |
    EGFR mutation • EGFR exon 20 insertion • EGFR exon 20 mutation • EGFR N771_P772insVal • EGFR S768_D770dup • EGFR S768_D770dupSVD
    |
    pemetrexed • Ivesa (firmonertinib)